PHENOMICS HEALTH INC.

Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, and the data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching; scientific and technological services in the field of pharmaceuticals featuring pharmacogenomic testing, analysis, and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of analyzing how an individual's cultural and environmental factors affect their response to drugs, and for the purposes of improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs switching; scientific and technological services, namely, scientific testing, evaluation, and analysis in the field of pharmaceuticals to determine a patient's medication and drug response associated with environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services, namely, scientific testing, evaluation, and analysis in the field of pharmaceuticals to determine a patient's medication and drug response associated with environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors, together with genetic variants, epigenetic factors and multiomics to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions for the purpose of supporting drug clinical trials and research into the field of new drug development and drug repurposing; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's cultural and environmental factors relating to medication treatment risk associated with adverse cultural environment, economic and community living conditions, including stress resulting from adverse conditions, age-related health, isolation or cognitive circumstances, behavior harmful to self or others, childhood and adolescent neglect and abuse, adult trauma associated with events, including sexual, physical and psychological abuse, acute or chronic traumatic events, including military conflict, crimes, crashes, illnesses and family deaths, stress, trauma, abuse, poverty, food insecurity and hunger, imprisonment, interpersonal conflict, violence, presence or absence of parents, children, siblings, and other family members and acquaintances, gender, ancestry, transgenerational social factors, age, income, marital status, education level, language, other household data, cultural situations, circadian data, ethnicity-related health, community living conditions, biological sex, ethnicity, and other non-genetic factors; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation to determine a patient's medication and drug response associated with cultural and environmental factors, including stress resulting from adverse conditions, age-related health, isolation or cognitive circumstances, behavior harmful to self or others, childhood and adolescent neglect and abuse, adult trauma associated with events, including sexual, physical and psychological abuse, acute or chronic traumatic events, including military conflict, crimes, crashes, illnesses and family deaths, stress, trauma, abuse, poverty, food insecurity and hunger, imprisonment, interpersonal conflict, violence, presence or absence of parents, children, siblings, and other family members and acquaintances, gender, ancestry, transgenerational social factors, age, income, marital status, education level, language, other household data, cultural situations, circadian data, ethnicity-related health, community living conditions, biological sex, ethnicity, and other non-genetic factors; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of one's periodic changes in response to medical treatment, pharmacological adverse reactions, drug-drug interactions, drug dosing changes, and new or recurring comorbidities

Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; scientific and technological services in the field of pharmaceuticals featuring pharmacogenomic testing analysis and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how an individual's genetic and non-genetic factors affect their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; scientific and technological services in the field of pharmaceuticals, namely, scientific testing, research, and analysis for the purpose of determining a patient's disease and drug response phenotype through evaluation of chromatin state, genomic regulatory elements, epigenomics, proteomics, metabolomics, transcriptomics, environmental factors, sociological factors, age, biological sex, ethnicity, and other non-genetic factors to predict pharmacological drug efficacy and adverse drug reaction phenotypes for patients; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of buccal, saliva, blood and other biological samples for the purposes of supporting drug clinical trials and research into the field of new drug development and drug repurposing

Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing

Medical testing, analysis, and evaluation services relating to the diagnosis and treatment of disease and other medical conditions, namely, testing, analysis and evaluation of blood and other biological samples for clinical treatment decision support purposes; Medical testing, analysis, and evaluation services in the nature of testing, analysis and evaluation of blood samples for diagnostic and treatment purposes; Medical testing, analysis, and evaluation services relating to the diagnosis and treatment of disease and other medical conditions in the nature of testing, analysis and evaluation of blood samples for the purpose of combining increased predictability of patient-specific drug efficacy, appropriate dose, drug-drug interactions, and likely adverse drug reactions with precise measurement of patient response to improve patient treatment outcomes, avoid adverse drug reactions, and reduce patient treatment costs; Scientific and technological services featuring testing, analysis and evaluation of human blood and other biological samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; Software as a service (SaaS) services featuring software for use in medical research data collection and management and database management, allowing physicians to share and receive clinical data, monitor patient data, monitor patient clinical data, monitor medications in a patient's circulation to support treatment decisions, develop clinical treatment decision support, develop other medical diagnostic products and prescription drugs for the purpose of improving patient outcomes in the field of healthcare, analyze and record testing, analysis and evaluation of human blood and other biological samples for the purposes of improving the identification and quantitative measurement of patient drug exposure, improving the monitoring and diagnosis of patient drug compliance, improving drug selection and dosage recommendations, improving the initial drug prescribing practices, and identifying drug-drug interactions; Platform as a Service (PaaS) featuring computer software that allows users to monitor patient data, patient clinical data, and medications in a patient's circulation to support treatment decisions; Providing an interactive website featuring technology that allows users to monitor patient data, patient clinical data, and medications in a patient's circulation to support treatment decisions; scientific and technological services, namely, providing medical and scientific research featuring testing, analysis and evaluation of blood samples for the purpose of improving the identification and quantitative measurement of patient drug exposure, improving the monitoring and diagnosis of patient drug compliance, improving drug selection and dosage recommendations, improving initial drug prescribing practices, identifying drug-drug interactions, developing clinical treatment decision support, and developing other medical diagnostic products and prescription drugs; scientific and technological services in the nature of testing, analysis and evaluation of blood and other biological samples for research purposes in the field of clinical trials; scientific and technological services, namely, research, analysis, and clinical testing in the fields of precision medicine for the purpose of combining pharmacogenomic drug treatment recommendations, identification and quantitative measurement of patient drug exposure with digital patient monitoring and digital therapy

Software as a service (SaaS) services featuring software for use in medical research data collection and management, database management, allowing physicians to share and receive clinical data, monitoring patient data, monitoring patient clinical data, monitoring medications in a patient's circulation to support treatment decisions, analyzing and recording testing, analysis and evaluation of blood samples for the purpose of improving the identification and quantitative measurement of patient drug exposure, improving the monitoring and diagnosis of patient drug compliance, improving drug dosage recommendations, initial drug prescribing practices, and identifying drug-drug interactions, and developing medical diagnostic products and prescription drugs for the purpose of improving patient outcomes in the field of healthcare; Platform as a Service (PaaS) featuring computer software that allows users to monitor patient data, patient clinical data, and medications in a patient's circulation to support treatment decisions; Providing an interactive website featuring technology that allows users to monitor patient data, patient clinical data, and medications in a patient's circulation to support treatment decisions; scientific and technological services, namely, providing medical and scientific research featuring testing, analysis and evaluation of blood samples for the purpose of improving the identification and quantitative measurement of patient drug exposure, improving the monitoring and diagnosis of patient drug compliance, improving drug dosage recommendations, initial drug prescribing practices, and identifying drug-drug interactions, and developing medical diagnostic products and prescription drugs; scientific and technological services in the nature of testing, analysis and evaluation of blood samples for research purposes and for research in the field of clinical trials | Medical testing, namely, testing, analysis and evaluation of blood samples for clinical treatment purposes; Medical testing services in the nature of testing, analysis and evaluation of blood samples for diagnostic and treatment purposes

Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes

Class 042: Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes

Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes

Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes

Scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes